BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:19 PM
 | 
Feb 06, 2008
 |  BC Extra  |  Company News

FDA accepts Cimzia BLA

FDA accepted a BLA from UCB (Euronext:UCB) for Cimzia certolizumab to treat adult patients with active rheumatoid arthritis (RA). UCB submitted the BLA in...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >